0000874716-23-000113.txt : 20230831 0000874716-23-000113.hdr.sgml : 20230831 20230831171705 ACCESSION NUMBER: 0000874716-23-000113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230829 FILED AS OF DATE: 20230831 DATE AS OF CHANGE: 20230831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POLEWACZYK JAMES F CENTRAL INDEX KEY: 0001389046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 231229477 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 wk-form4_1693516123.xml FORM 4 X0508 4 2023-08-29 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001389046 POLEWACZYK JAMES F ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President 0 Common Stock 2023-08-29 4 M 0 2627 68.75 A 18664.9875 D Common Stock 2023-08-29 4 M 0 706 141.60 A 19370.9875 D Common Stock 2023-08-29 4 M 0 7151 141.60 A 26521.9875 D Common Stock 2023-08-29 4 M 0 560 178.26 A 27081.9875 D Common Stock 2023-08-29 4 M 0 5865 178.26 A 32946.9875 D Common Stock 2023-08-29 4 S 0 500 508.9642 D 32446.9875 D Common Stock 2023-08-29 4 S 0 2545 509.3207 D 29901.9875 D Common Stock 2023-08-29 4 S 0 6186 510.3776 D 23715.9875 D Common Stock 2023-08-29 4 S 0 3318 510.4664 D 20397.9875 D Common Stock 2023-08-29 4 S 0 7473 511.0286 D 12924.9875 D Common Stock 2023-08-29 4 S 0 2887 511.2237 D 10037.9875 D Non-Qualified Stock Option (right-to-buy) 68.75 2023-08-29 4 M 0 2627 0 D 2026-02-13 Common Stock 2627 0 D Incentive Stock Option (right-to-buy) 141.60 2023-08-29 4 M 0 706 0 D 2027-02-13 Common Stock 706 0 D Non-Qualified Stock Option (right-to-buy) 141.60 2023-08-29 4 M 0 7151 0 D 2027-02-13 Common Stock 7151 0 D Incentive Stock Option (right-to-buy) 178.26 2023-08-29 4 M 0 560 0 D 2028-02-13 Common Stock 560 0 D Non-Qualified Stock Option (right-to-buy) 178.26 2023-08-29 4 M 0 5865 0 D 2028-02-13 Common Stock 5865 0 D Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023. Represents the weighted average price of the shares sold ranging from a low of $508.76 to a high of $509.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $508.63 to a high of $509.63 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $509.69 to a high of $510.68 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $509.93 to a high of $510.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $510.73 to a high of $511.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $510.96 to a high of $511.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy 12,627 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017. Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022. Grant of option to buy 7,151 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018. Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023. Grant of option to buy 5,865 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019. /s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk 2023-08-31